PCI Biotech Holding ASA - Annual Report 2023
26 avr. 2024 02h08 HE
|
PCI Biotech Holding ASA
Oslo, Norway, April 26, 2024.The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2023. Please find the report attached, as well as the report according to the European...
PCI Biotech second half 2023 interim results
14 févr. 2024 01h00 HE
|
PCI Biotech Holding ASA
Oslo (Norway), 14 February 2024 – PCI Biotech (OSE: PCIB), today announces its interim second half 2023 results. Please find enclosed the interim report and presentation. Highlights review ...
PCI Biotech: Invitation to second half interim 2023 results presentation
12 févr. 2024 03h26 HE
|
PCI Biotech Holding ASA
Oslo, Norway, 12 February 2024 - PCI Biotech (OSE: PCIB) invites to a webcast presentation of the company's second half 2023 interim report on Wednesday 14 February 2024, 08:30am – 09:30am CET (local...
PCI Biotech initiates field testing of its proprietary technology for gene therapy manufacturing
13 oct. 2023 04h17 HE
|
PCI Biotech Holding ASA
Oslo, Norway, 13 October 2023 – PCI Biotech (OSE: PCIB) today announced a research collaboration agreement with the aim to address critical pain points in the manufacturing of gene therapies. The...
PCI Biotech: European patent for mRNA delivery with fimaNAc
07 sept. 2023 06h36 HE
|
PCI Biotech Holding ASA
Oslo (Norway), 7 September 2023 – PCI Biotech (OSE: PCIB), a biopharmaceutical company, today announces that the European Patent Office (EPO) has informed PCI Biotech that they intend to grant a new...
PCI Biotech: Employee share option scheme
04 sept. 2023 04h14 HE
|
PCI Biotech Holding ASA
Oslo, 4 September 2023 - PCI Biotech (OSE: PCIB), today announce that the Board of Directors has granted share options to key employees. In accordance with the authorisation granted by the...
PCI Biotech: Write-down of share capital registered
01 sept. 2023 05h04 HE
|
PCI Biotech Holding ASA
Oslo, Norway, 1 September 2023 – PCI Biotech Holding ASA (OSE: PCIB) Reference is made to the resolution made by the Annual General Meeting 25 May 2023, in respect of a write-down of share capital by...
PCI Biotech first half 2023 interim results
31 août 2023 01h00 HE
|
PCI Biotech Holding ASA
Oslo (Norway), 31 August 2023 – PCI Biotech (OSE: PCIB), today announces its interim first half 2023 results. Please find enclosed the report and presentation.Highlights review fimaNAc –...
PCI Biotech: Invitation to first half interim 2023 results presentation
25 août 2023 08h30 HE
|
PCI Biotech Holding ASA
Oslo, Norway, 25 August 2023 - PCI Biotech (OSE: PCIB) invites to a webcast presentation of the company's first half 2023 interim report on Thursday 31 August 2023, 08:30am – 09:30am CEST (local...
Minutes from Annual General Meeting 2023
25 mai 2023 05h38 HE
|
PCI Biotech Holding ASA
Oslo, 25 May 2023. The Annual General Meeting in PCI Biotech Holding ASA took place today, 25 May 2023. All the matters on the agenda were approved and the minutes of the Annual General Meeting are...